Achiko

Enable to Pay | Things to Do | Places to Be

  • About
  • Products
  • Team
  • News
    • Announcements
    • Media
    • Research
    • Financials
  • Careers
  • Contact
  • English
    • German
    • French

Achiko secures convertible loan facility with Yorkville Advisors of USD 2.5 million, with a provisional extension of up to USD 9.5 million

November 26, 2020

Zurich, 26 November 2020 – Achiko AG (SWX:ACHI, ISIN CH0522213468) announces the completion of a convertible loan facility with US based fund manager Yorkville Advisors Global LP (“Yorkville”), signing a convertible loan facility of up to USD 12 million. It is constituted of a committed USD 2.5 … [Read more...]

Filed Under: News

Achiko AG appoints Toolbox Medical Innovations and NDA Group and expands Advisory Board

November 2, 2020

Encouraging initial results to date in field validation trialsToolbox Medical Innovations engaged for the design of the commercial test kitNDA Group engaged to assist in progress towards CE markingAdditional international advisory board members: Paul Field (Australia) and Charles Pan … [Read more...]

Filed Under: News

Achiko AG Completes Capital Increase

October 30, 2020

Zurich, 30 October 2020 – Achiko AG (SWX:ACHI, ISIN CH0522213468) announces that following the financing round communicated on the 29th July 2020, its share capital recorded in the commercial register has been increased by 13,165,476 shares to 102,797,618 shares. The new shares have been issued out … [Read more...]

Filed Under: News

Achiko Establishes Medtech Expert Advisory Board and Expands Management Team

October 13, 2020

New international advisory board members: Mr Glenn Cross (Australia), Dr Jittaporn Wattanaseree (Thailand) and Ms Carol Aebi (Switzerland)Management team appointment: Mr Pierre Nathie of Med2Mark as VP, CommercialisationZurich, 13 October 2020--Achiko AG (SWX:ACHI, ISIN CH0522213468) is pleased … [Read more...]

Filed Under: News

Achiko AG Announces Half-Year Results per June 30 2020

September 28, 2020

The outbreak of the Covid-19 pandemic towards the end of first quarter 2020 limited Achiko’s ability to execute on its business strategyAchiko responded by developing a Covid-19 testing and ecosystem platform Teman Sehat, and by securing a complementary testing technology codenamed “Gumnuts” to … [Read more...]

Filed Under: News

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Next Page »

      Privacy Policy     Terms & Conditions    
Copyright © Achiko AG 2021